Cargando…

The role of the tumour microenvironment in the angiogenesis of pituitary tumours

PURPOSE: Angiogenesis has been studied in pituitary neuroendocrine tumours (PitNETs), but the role of the tumour microenvironment (TME) in regulating PitNET angiogenesis remains unknown. We aimed to characterise the role of TME components in determining the angiogenetic PitNET profile, focusing on i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marques, Pedro, Barry, Sayka, Carlsen, Eivind, Collier, David, Ronaldson, Amy, Dorward, Neil, Grieve, Joan, Mendoza, Nigel, Nair, Ramesh, Muquit, Samiul, Grossman, Ashley B., Korbonits, Márta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674353/ https://www.ncbi.nlm.nih.gov/pubmed/32946040 http://dx.doi.org/10.1007/s12020-020-02478-z

Ejemplares similares

Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours
por: Marques, Pedro, et al.
Publicado: (2019)

MON-462 Cytokine Network in Pituitary Adenomas and Its Role in the Tumor Microenvironment: Focus on Macrophages
por: Marques, Pedro, et al.
Publicado: (2019)

MON-460 Pasireotide Treatment Inhibits Cytokine Release from Pituitary Adenoma-Associated Fibroblasts: Is This Mechanism Playing a Key Role in Its Effect?
por: Marques, Pedro, et al.
Publicado: (2019)

Tumor microenvironment defines the invasive phenotype of AIP-mutation-positive pituitary tumors
por: Barry, Sayka, et al.
Publicado: (2019)

Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours
por: Iacovazzo, Donato, et al.
Publicado: (2019)

The clinical aspects of pituitary tumour genetics
por: Dénes, Judit, et al.
Publicado: (2021)

PMON170 Treating human primary non-functioning pituitary adenoma cells with cabergoline
por: Begalli, Federica, et al.
Publicado: (2022)

Emergence of Pituitary Adenoma in a Child during Surveillance: Clinical Challenges and the Family Members' View in an AIP Mutation-Positive Family
por: Marques, Pedro, et al.
Publicado: (2018)

Pituitary haemorrhage and infarction: the spectrum of disease
por: Iqbal, Fizzah, et al.
Publicado: (2021)

Coexisting pituitary and non‐pituitary gigantism in the same family
por: Marques, Pedro, et al.
Publicado: (2018)

Proteoglycans in cancer biology, tumour microenvironment and angiogenesis
por: Iozzo, Renato V, et al.
Publicado: (2011)

The role of tumour microenvironment in gastric cancer angiogenesis
por: Brzozowa, Marlena, et al.
Publicado: (2014)

Posterior pituitary tumours: patient outcomes and determinants of disease recurrence or persistence
por: Das, Liza, et al.
Publicado: (2021)

Skull base repair following endonasal pituitary and skull base tumour resection: a systematic review
por: Khan, Danyal Z., et al.
Publicado: (2021)

Significant Benefits of AIP Testing and Clinical Screening in Familial Isolated and Young-onset Pituitary Tumors
por: Marques, Pedro, et al.
Publicado: (2020)

Activation of the GPR35 pathway drives angiogenesis in the tumour microenvironment
por: Pagano, Ester, et al.
Publicado: (2022)

Proliferation, bcl-2 expression and angiogenesis in pituitary adenomas: relationship to tumour behaviour
por: Turner, H E, et al.
Publicado: (2000)

Succinate dehydrogenase and MYC-associated factor X mutations in pituitary neuroendocrine tumours
por: Loughrey, Paul Benjamin, et al.
Publicado: (2022)

Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 1 – molecular pathways
por: Cakir, Mehtap, et al.
Publicado: (2010)

Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 2 – clinical implications
por: Cakir, Mehtap, et al.
Publicado: (2010)

Adrenomedullin and tumour angiogenesis
por: Nikitenko, L L, et al.
Publicado: (2006)

Breast tumour angiogenesis
por: Fox, Stephen B, et al.
Publicado: (2007)

Imaging tumour angiogenesis
por: Jeswani, Tony, et al.
Publicado: (2005)

ACTH Secreting Pituitary Tumours
por: Nabarro, J. D. N.
Publicado: (1977)

Architects of Pituitary Tumour Growth
por: Sabatino, Maria Eugenia, et al.
Publicado: (2022)

The Role of CDK5 in Tumours and Tumour Microenvironments
por: Do, Phuong Anh, et al.
Publicado: (2020)

Adrenomedullin and tumour microenvironment
por: Larráyoz, Ignacio M, et al.
Publicado: (2014)

The hypoxic tumour microenvironment
por: Petrova, Varvara, et al.
Publicado: (2018)

Neuroendocrine tumours and their microenvironment
por: de Hosson, Lotte D., et al.
Publicado: (2020)

Beyond the tumour microenvironment
por: Laplane, Lucie, et al.
Publicado: (2019)

Urokinase and macrophages in tumour angiogenesis.
por: Hildenbrand, R., et al.
Publicado: (1995)

PHD2 in tumour angiogenesis
por: Chan, D A, et al.
Publicado: (2010)

Host microenvironment in breast cancer development: Inflammatory and immune cells in tumour angiogenesis and arteriogenesis
por: Yu, Joanne L, et al.
Publicado: (2003)

Bufalin suppresses tumour microenvironment-mediated angiogenesis by inhibiting the STAT3 signalling pathway
por: Fang, Kai, et al.
Publicado: (2021)

The role of tumour-derived iNOS in tumour progression and angiogenesis
por: Kostourou, V, et al.
Publicado: (2011)

Functional Acidophilic Tumours of the Pituitary of the Rat
por: Bielschowsky, F.
Publicado: (1954)

Tumour-associated macrophages: versatile players in the tumour microenvironment
por: Ji, Zoey Zeyuan, et al.
Publicado: (2023)

Multi-chaperone function modulation and association with cytoskeletal proteins are key features of the function of AIP in the pituitary gland
por: Hernández-Ramírez, Laura C., et al.
Publicado: (2018)

Clinical and Pathological Aspects of Silent Pituitary Adenomas
por: Drummond, Juliana, et al.
Publicado: (2018)

Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours
por: Cheng, Ya Qi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7jv1mj2j7gs8goupge9ncvov71